Effect of erythrocytes of androgens on 2,3-diphosphoglycerate in patients with chronic obstructive pulmonary diseaseChest
AbstractBecause androgen therapy is known to increase 2,3-diphosphoglycerate in the erythrocytes of patients with chronic renal failure, the possibility that it might have a similar effect on patients with chronic obstructive pulmonary disease appeared worth investigating. Results of a small study appear promising, with improvement in stress tolerance and general well-being. Pulmonary function was not improved, and the severity of pulmonary disease was not affected, but further investigation of the treatment appears to be warranted.
Citation InformationJohn P. Simelaro, Michael Venditto and M. Ghens. "Effect of erythrocytes of androgens on 2,3-diphosphoglycerate in patients with chronic obstructive pulmonary disease" Chest Vol. 76 Iss. 2 (1980) p. 240 - 241
Available at: http://works.bepress.com/john_simelaro/8/